The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis - PubMed (original) (raw)
Review
The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis
Daniela Alfano et al. Thromb Haemost. 2005 Feb.
Abstract
The urinary-type plasminogen activator, or uPA, controls matrix degradation through the conversion of plasminogen into plasmin and is regarded as the critical trigger for plasmin generation during cell migration and invasion, under physiological and pathological conditions (such as cancer metastasis). The proteolytic activity of uPA is responsible for the activation or release of several growth factors and modulates the cell survival/apoptosis ratio through the dynamic control of cell-matrix contacts. The urokinase receptor (uPAR), binding to the EGF-like domain of uPA, directs membrane-associated extracellular proteolysis and signals through transmembrane proteins, thus regulating cell migration, adhesion and cytoskeletal status. However, recent evidence highlights an intricate relationship linking the uPA/uPAR system to cell growth and apoptosis.
Comment in
- Proteases and extracellular environment.
Del Rosso M, Fibbi G, Schmitt M, Mignatti P. Del Rosso M, et al. Thromb Haemost. 2005 Feb;93(2):190-1. Thromb Haemost. 2005. PMID: 15711731 No abstract available.
Similar articles
- The urokinase-system--role of cell proliferation and apoptosis.
Hildenbrand R, Gandhari M, Stroebel P, Marx A, Allgayer H, Arens N. Hildenbrand R, et al. Histol Histopathol. 2008 Feb;23(2):227-36. doi: 10.14670/HH-23.227. Histol Histopathol. 2008. PMID: 17999379 Review. - Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Plesner T, Behrendt N, Ploug M. Plesner T, et al. Stem Cells. 1997;15(6):398-408. doi: 10.1002/stem.150398. Stem Cells. 1997. PMID: 9402652 Review. - The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy.
Sidenius N, Blasi F. Sidenius N, et al. Cancer Metastasis Rev. 2003 Jun-Sep;22(2-3):205-22. doi: 10.1023/a:1023099415940. Cancer Metastasis Rev. 2003. PMID: 12784997 Review. - Regulation and role of urokinase plasminogen activator in vascular remodelling.
Tkachuk V, Stepanova V, Little PJ, Bobik A. Tkachuk V, et al. Clin Exp Pharmacol Physiol. 1996 Sep;23(9):759-65. doi: 10.1111/j.1440-1681.1996.tb01177.x. Clin Exp Pharmacol Physiol. 1996. PMID: 8911711 Review. - Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis.
Choong PF, Nadesapillai AP. Choong PF, et al. Clin Orthop Relat Res. 2003 Oct;(415 Suppl):S46-58. doi: 10.1097/01.blo.0000093845.72468.bd. Clin Orthop Relat Res. 2003. PMID: 14600592 Review.
Cited by
- Regulation of urokinase receptor expression by p53: novel role in stabilization of uPAR mRNA.
Shetty S, Velusamy T, Idell S, Shetty P, Mazar AP, Bhandary YP, Shetty RS. Shetty S, et al. Mol Cell Biol. 2007 Aug;27(16):5607-18. doi: 10.1128/MCB.00080-07. Epub 2007 Jun 4. Mol Cell Biol. 2007. PMID: 17548471 Free PMC article. - Inhibition of neutrophil apoptosis by PAI-1.
Zmijewski JW, Bae HB, Deshane JS, Peterson CB, Chaplin DD, Abraham E. Zmijewski JW, et al. Am J Physiol Lung Cell Mol Physiol. 2011 Aug;301(2):L247-54. doi: 10.1152/ajplung.00075.2011. Epub 2011 May 27. Am J Physiol Lung Cell Mol Physiol. 2011. PMID: 21622848 Free PMC article. - Regulation of proteinases during mouse peri-implantation development: urokinase-type plasminogen activator expression and cross talk with matrix metalloproteinase 9.
Martínez-Hernández MG, Baiza-Gutman LA, Castillo-Trápala A, Armant DR. Martínez-Hernández MG, et al. Reproduction. 2011 Feb;141(2):227-39. doi: 10.1530/REP-10-0334. Epub 2010 Nov 12. Reproduction. 2011. PMID: 21075828 Free PMC article. - The overexpression of uPA promotes the proliferation and fibrinolytic activity of human umbilical vein endothelial cells.
Song T, Meng S, Xu ST, Jin SJ, Zeng QZ, Gu GJ. Song T, et al. Int J Clin Exp Pathol. 2019 Aug 1;12(8):2959-2966. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31934132 Free PMC article. - The Plasminogen Activation System Promotes Dendritic Spine Recovery and Improvement in Neurological Function After an Ischemic Stroke.
Jeanneret V, Yepes M. Jeanneret V, et al. Transl Stroke Res. 2016 Feb 4:10.1007/s12975-016-0454-x. doi: 10.1007/s12975-016-0454-x. Online ahead of print. Transl Stroke Res. 2016. PMID: 26846991 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous